Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

42541 - 42550 of 44979 results found

Liver and Renal Injury with Remdesivir Treatment in SARS-CoV-2 Patients

Date
Thursday, March 23, 2023 - 4:00 AM
Description
CONCLUSION: Only three patients developed adverse effects resulting in stopping of Remdesivir, however these were reversible on stopping the drug. Therefore, Remdesivir is a relatively safe drug and well tolerated in SARS-CoV-2 patients.